Profil
David S.
Johnson is the founder of GigaGen, Inc., a company founded in 2010, where he holds the title of President, Chief Executive Officer & Director.
He is currently working at GigaMune, Inc. as the Secretary, Chief Executive & Financial Officer.
Dr. Johnson has previously worked as a Project Director at Stanford University and as the Chief Operating Officer at Natera, Inc. He has an undergraduate degree from Duke University, a doctorate from Stanford University, and an MBA from Haas School of Business.
Aktive Positionen von David S. Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
GigaGen, Inc.
 GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Gründer | 01.01.2010 |
GigaMune, Inc.
 GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von David S. Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| NATERA, INC. | Geschäftsführer | - |
| Stanford University | Corporate Officer/Principal | - |
Ausbildung von David S. Johnson
| Duke University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| Haas School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Health Technology |
GigaMune, Inc.
GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Health Technology |
